Amanote Research

Amanote Research

    RegisterSign In

Communication About the Risks and Benefits of Phase I Pediatric Oncology Trials

Contemporary Clinical Trials - Netherlands
doi 10.1016/j.cct.2015.01.015
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicinePharmacology
Date

March 1, 2015

Authors
Rebecca A. HazenStephen ZyzanskiJustin N. BakerDennis DrotarEric Kodish
Publisher

Elsevier BV


Related search

Predictors of Success of Phase II Pediatric Oncology Clinical Trials

Oncologist
Cancer ResearchMedicineOncology
2019English

A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies

Oncologist
Cancer ResearchMedicineOncology
2020English

Toxicity of Phase I Radiation Oncology Trials: Worldwide Experience

2010English

Pediatric Computed Tomography Scans: Weighing the Risks and Benefits

Cancer
Cancer ResearchOncology
2019English

Relationship Between Response and Dose in Published, Contemporary Phase I Oncology Trials

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2020English

Palliative Care: Toy Therapy Benefits of Pediatric Oncology

2018English

Perceptions and Referral Trends Into Phase I Oncology Trials: Results of a Clinical Survey

Journal of Oncology
Oncology
2011English

When Parents Have Misunderstandings About the Risks and Benefits of Palliative Surgery

Pediatrics
Child HealthPediatricsPerinatology
2018English

The Role of Social Media in Communication About Food Risks

British Food Journal
AccountingManagementFood ScienceBusiness
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy